HLE Glascoat LtdQ3 FY22Industrial Manufacturing

HLE Glascoat Ltd

Q3 FY22 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→The company has a robust and healthy order book providing good visibility for the near term, with approximately 5 months for India and 8-9 months for Europe.
→There is a consistently strong inquiry pipeline and ongoing conversations with large customers supporting medium-term demand visibility.
→Integration with Thaletec is progressing well, expected to drive top-line growth and margin improvement.
→A growing installed base is boosting after-sales services, contributing 7-8% of Indian revenues and up to 40% in European markets.
→Expansion via Silvassa plant capex has increased manufacturing capacity, with the plant already operating at 65-70%, expected to boost future dispatches.
→Replacement demand is rising due to aging installed equipment (15-25 years old), alongside a shift towards modern filtration and drying technology replacing legacy methods.
→The company remains confident of sustained growth over the next 2-3 years, supported by global trends like China+1 strategy and localized production demands in Europe and India.

Margin guidance

Category 3

→The Company has a robust order book: approx. 5 months for India and 8-9 months for Europe, indicating near-term revenue visibility.
→Integration with Thaletec is progressing well, expected to drive top-line growth and margin improvement.
→Capacity utilization is high: 70-75% for filtration and drying, over 80% for glass-lined equipment, with Silvassa plant’s ramp-up expected to boost production and sales in coming quarters.
→Operational excellence and completed capex projects (e.g., Silvassa plant) contribute to capacity growth and efficiencies.
→Margins are expected to improve as raw material price volatility has reduced, enabling better price pass-through.
→After-sales and service business, which is higher margin and growing (7-8% revenue in India, ~40% in Europe), is expanding.
→Medium to long-term growth supported by ongoing demand in specialty chemicals, pharma, and agrochemical sectors.
→Management confident of steady revenue and margin growth over medium term despite short-term inflationary pressures.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for HLE Glascoat Ltd and 1,400+ other companies.

Fundraise plans

The transcript provided does not mention any current or future plans for fundraising through debt or equity for HLE Glascoat Limited. Key points related to finances are: - Discussion mainly revolves around operational performance, capacity, order book, and integration with Thaletec. - Finance cost increased due to guarantee commissions linked to performance guarantees for installations, not new borrowings. - Working capital is currently elevated due to Silvassa plant operation and high order book but expected to normalize. - No explicit mention of new debt or equity raising plans during the call. Hence, based on the available transcript pages, there is no indication of any planned or ongoing fundraising through debt or equity.

Order book

Yes

→The company currently holds an order book of approximately five months for the India business and about 8 to 9 months for the European business.
→The order book and inquiry pipeline are healthy, providing visibility for a few quarters ahead.
→Consistent booking of new orders continues, contributing to confidence in short-term and medium-term performance.
→Discussions with large customers and ongoing inquiries offer insights supporting a positive outlook for growth over the next 12 to 24 months.
→The order book typically provides operational visibility of plus-minus six months, with the inquiry pipeline complementing longer-term planning.
→Despite global supply chain disruptions, the company remains confident in both the immediate and medium-term demand outlook.

Capex plans

Yes

→Silvassa Capex has been completed and Silvassa plant is currently operating at around 65%-70% manufacturing output.
→The ramp-up of dispatches from Silvassa is expected to happen in Q3 and Q4, with a production cycle of about 3-4 months.
→The Company is undertaking continuous improvement and internal operational excellence projects to optimize capacity utilization across plants.
→Focus remains on growing capacity utilization above current levels, which is one rationale behind the Silvassa Capex.
→No specific future capex or strategic investment details beyond Silvassa are explicitly mentioned in the provided transcript.
→Integration efforts continue with Thaletec, including technology transfer and cross-selling synergies, enhancing existing investments rather than new capex.
→The Company is monitoring energy cost impacts and subsidies, especially for overseas operations, to inform future operational investments.

How does HLE Glascoat Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1HLE Glascoat Ltd

Rev 2Mar 3

See full Industrial Manufacturing sector rankings

Unlock with Pro

Want more stocks like HLE Glascoat Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio